NEW⇒C17 100% Fund Grant Competition Targeting RHABDOMYOSARCOMA. Registration due 13-Sept-19. Grants due 25-Oct-19. Spread the word!!
C17 is pleased to announce a SUPPLEMENTAL COMPETITION for the The 100% Fund Grant Competition targeting rhabdomyosarcoma. This competition does not replace the regular fall competition. It is an additional funding opportunity.
The purpose of The 100% Fund Grant Competition is to target directly pediatric cancers that are rare and hard to treat—cancers that have not responded to available therapies. Applications addressing rhabdomyosarcoma will be considered for the 2019 100% Fund Grant Competition (Round 3).
Projects can range from discovery to clinical trials, but must be focused towards a treatment intervention. The goal is to fund research with the potential to deliver improved treatment and increased survival rates.
This supplemental competition will use a very short LETTER OF REGISTRATION, and not a longer letter of intent.
- The letter of registration (LOR) is due by 13-Sep-2019 (4pm MT).
- The LOR is NOT REVIEWED.
- All applicants who submit a registration by the due date will automatically advance to the grant application stage.
- Grants are due by 25-Oct-2019 (4 pm MT).
- Results will be returned with sufficient time for unsuccessful applicants to submit to the 2019/2020 C17 grant competition, going directly to the grant stage.
- The registration form can be downloaded from the link below or from C17.ca.
Files for download
- The 100% Fund Rhabdomyosarcoma Round 3 Call for Letters of Registration
- C17 100% Fund (Round 3)—Rhabdomyosarcoma LOR form
(LOR due 13-Sept-2019 4pm MT)
- C17 100% Fund (Round 3)—Rhabdomyosarcoma grant application form (grants due 25 Oct-2019 4pm MT)
- C17 Application Instructions and Award Guide (ver 13-Nov-2018)
Application forms and the guidance document also can be downloaded from the C17 website (www.c17.ca) under Committees> Research Network.
There is still time to register for the next CCTG New Investigator Clinical Trials Course (NICTC) being held August 7th to the 9th in Kingston, Ontario.
The NICTC is an important component of the group mandate to provide and facilitate investigator education and training. The major goal of the course is to familiarize new investigators from across the country with the essentials of clinical trial conduct in the Canadian research environment.
The intended audience for this course is junior level faculty, fellows in oncology and translational scientists. This two day intensive provides clinical researchers in oncology with the basic tools for a future career in clinical research and will be accredited for Maintenance of Competence (MOCOMP) credits with the Royal College of Physicians and Surgeons of Canada. The 2019 New Investigator Clinical Trials Course marks the seventh anniversary of the course, originally founded in 2007.
The C17 Council has the following position open for consideration:
Co-Chair, C17 Education Committee (MD position)
The C17 Council is searching for a Co-Chair for the C17 Education committee. The C17 Education committee is responsible for the national videoconference, and Norma Auger Scholarship program. The C17 Education committee is also the umbrella committee for all other C17 education initiatives, such as Fellowship conferences, Laboratory training, Royal College, educational website, etc. The Co-Chair will work closely with the affiliated health care Co-Chair and be co-responsible for budgets, decisions of the committee, attendance on Council teleconferences and meetings. The Co-Chair, C17 Education committee will serve a term of 3 years, renewable once. (After two terms, a new election will be called, but does not exclude any incumbent from standing for additional terms).
Requirements: Physician interested in working with the C17 Council and Canadian health professionals on educational initiatives in the area of pediatric and AYA oncology, hematology and bone marrow transplant.
Deadline: Nominations will be accepted until 22 July 2019.
Nominations may be submitted by an individual interested in the position or a member of C17 to Dr. Conrad Fernandez, Chair of the C17 Nomination Committee and Kathy Brodeur-Robb, Executive Director, C17 Council, by email at Conrad.firstname.lastname@example.org and email@example.com.
The nominee must indicate that they accept the nomination, provide a brief description of their qualifications, vision and goals for the position, and provide a copy of their CV. Nominations will be accepted until the deadline listed. The position will be voted on by the C17 Council.
The Division of Pediatric Hematology/Oncology of the Montreal Children’s Hospital, McGill University Health Centre is seeking a full-time clinician for an academic appointment commensurate with qualifications and experience.
The individual would become part of an experienced and cohesive group caring for a broad range of patients within the specialty. An interest in malignant hematology/oncology is preferred and a record of clinical research would be an asset. Candidates must have completed a fellowship in pediatric hematology/oncology and be board certified or eligible by the Royal College of Physicians and Surgeons of Canada or equivalent body. Due to regulations of the Collège des Médecins du Québec candidates who completed their medical school training outside of North America, France, or Belgium will not be considered. In accordance with Canadian immigration requirements, priority will be given to Canadian citizens and permanent residents. The MUHC is committed to providing equal employment opportunity to qualified individuals with diverse backgrounds and experiences including aboriginal people, visible minorities, and those with disabilities.
Interested individuals should send a letter of application, curriculum vitae, and the names and addresses of three referees to:
Dr. David Mitchell
Division Director, Pediatric Hematology/Oncology
Montreal Children’s Hospital
1001 Blvd Décarie, Room B05.2024
Montréal, Québec, Canada H4A 3J1
About the Division and Montreal Children’s Hospital
The MCH is a full service academic pediatric hospital that has had international influence in the care of children for over 110 years. In 2015 it relocated to a brand new and very unique facility that is comprised of separate pediatric and adult hospitals, a Shriners Hospital, cancer centre, and basic research institute on one site. Collaboration between all clinical and research sectors is facilitated with all buildings being attached. The division of hematology/oncology is located within the pediatric hospital with dedicated and adjacent inpatient and outpatient units. The division sees 90-100 new oncology cases annually and a full range of benign hematology patients including 200 with sickle cell disease. Within the division there is particular expertise in hematopoietic stem cell transplantation, hemostasis, thrombosis, hemoglobinopathies, long term follow-up, neuro-oncology, and cancer genetics and we are very active in clinical, basic, and translational research.
Greater Montreal is a city of 4 million people with a very multicultural and cosmopolitan flavor. French and English are the dominant languages and ability to communicate in both would be an asset. It is renowned for its summer festivals, excellent selection of restaurants, proximity to world class skiing, and the opportunity for a high standard of living with the cost of real estate considerably lower than many other major metropolitan areas in Canada and United States.
JOB POSTING at the UofA with partner organization Solutions for Kids in Pain (SKIP) – Knowledge Broker (bachelor’s or master’s degree in relevant discipline required; apply by June 20)
Dear Alberta Based SKIP Partners and Friends:
We have a full-time Solutions for Kids in Pain (SKIP) Knowledge Broker position based at Stollery Children’s/University of Alberta, supervised by our amazing Edmonton-based SKIP Hub lead Dr. Samina Ali. The posting ends June 20th. Can you help us spread the word? This is a great employment opportunity for the right person!
A minimum of Bachelor’s Level education in a relevant discipline (e.g., science, health administration, communication, or equivalent); Master’s degree preferred
Complete position description can be found at:
Please see the complete job posting at: https://cusm.njoyn.com/cl3/xweb/Xweb.asp?tbtoken=ZVpaRB4XCG1xZXN0TVVUCCNLAxdEcCJZAUhZVFEJExEpKjZvKEITdWAGdwkbURBQTXIqWA%3D%3D&chk=dFlbQBJe&CLID=55242&page=jobdetails&JobID=J0519-1247&brid=20082&lang=1
RESEARCH INSTITUTE OF THE MUHC
The Research Institute of the McGill University Health Centre (RI-MUHC) is a world-renowned biomedical and hospital research centre. Located in Montreal, Quebec, the Institute is the research arm of the McGill University Health Centre (MUHC) affiliated with the Faculty of Medicine at McGill University. The RI-MUHC is supported in part by the Fonds de recherche du Québec – Santé (FRQS).
The MUHC Pediatric Hematology/Oncology Research Program aims to promote and improve the health of children and young adults diagnosed with cancer or hematological disorders. We support and conduct research and research training in health and illness with the goal of facilitating the development and implementation of clinical trials, biobanks, cancer control, and nurse-initiated studies and protocols. Ongoing efforts to strengthen the interdisciplinary aspects of research are a priority for us.
The purpose of this job is to initiate and coordinate clinical trials according to regulatory and institutional guidelines and requirements, register eligible participants, manage the studies, extract, compile and submit data, monitor study compliance, monitor and maintain on-going regulatory requirements, provide information and feedback on designated clinical trial studies.
Education / Experience
- Work experience: Minimum of two (2) years of experience in clinical research. Certified Clinical Research Professional (through SoCRA or ACRP or equivalent organization) preferred,
- Education: Minimum of a DEC in nursing (Registered Nurse),
- Good standing with the OIIQ,
- Excellent communication skills in French and English, spoken and written,
- Strong analytical skills and ability to synthesize complex material clearly,
- Excellent interpersonal and leadership skills,
- Ability to work effectively in a team and autonomously,
- Exceptional organizational skills, meticulous and detail-oriented,
- Motivated and enthusiastic,
- Able to work in an environment with children and young adults with cancer,
- Comprehensively use computer software and technology
If you don’t share your pediatric/AYA research with Canadian cancer research community, who will? Last day to submit an abstract is June 14th.
Find instructions for abstract submission here:
The Canadian Cancer Research Conference provides an excellent opportunity to present pediatric/AYA research to the cancer community. Abstract submissions from the entire spectrum of research topics are welcome. Trainees (undergraduate students, graduate students, and postdoctoral fellows) and new principal investigators are encouraged to present their work.
The online abstract submission process is bilingual. Abstract submissions will be accepted in both English and French. Abstracts will appear in the language of submission, and posters may be prepared and presented orally in the presenter’s language of choice.
The fifth Canadian Cancer Research Conference will be held from November 3 to 5, 2019 at the Shaw Centre, in Ottawa, Ontario. The last conference was held in 2017 with 1040 conference attendees, 696 abstract submissions, 596 poster presentations, 33 abstract selected speakers, 25 concurrent sessions and 3 plenary sessions.
Abstract submissions for oral and poster presentations will remain open until June 14, 2019.
The scientific program will consist of plenary sessions, concurrent sessions, and poster sessions featuring leading national and international researchers from across the cancer research spectrum.
Collectively, the conference’s scientific program will provide attendees with opportunities to network, learn about cutting-edge research in Canada, and present results to and receive feedback from colleagues from across the country.
Plenary session topics include:
- Novel Cancer Immunotherapies
- Cancer Genetics and Precision Oncology
- Future of Cancer Research
The working list of regular sessions includes:
- Innovations in Cancer Proteomics
- Tumour and Immune Microenvironment
- Pediatric and AYA Oncology
- Stakeholder/Patient Engagement, Patient Oriented Research
- Indigenous Populations and Cancer
- Immunotherapy: Adoptive Cell Therapy
- Cancer Stem Cells and Cellular Plasticity
- Rare Cancers
- Real World Evidence
- Early Detection and Risk Prediction
- Mechanisms of Cancer Resistance
- Model Systems
- Occupational and Environmental Exposure
- Cancer Imaging and Profiling
- Integration of Palliative Care Prevention
- Consortium Based Research
- Lessons from Aging
- Poor Survival Cancers
- Equity and Equality
- Cannabis, Vaping, ECigarettes, and Tobacco
JOB POSTING: Healthcare Analyst at the PEDIATRIC ONCOLOGY GROUP OF ONTARIO (POGO) [competition closed 10-June-2019]
Download the complete job posting at: https://www.pogo.ca/wp-content/uploads/2019/05/Job-Posting-Healthcare-Analyst-May-2019.pdf
The Healthcare Analyst at POGO will have strong analytic skills to solve complex data problems using SAS (Statistical Analysis System), excellent research skills, and strong project management skills to support health analytics, policy and program development and health system quality monitoring and surveillance. POGO provides a stimulating work environment for inter-institutional, multidisciplinary and multidimensional policy development. This position offers a unique opportunity to contribute to the implementation of POGO’s System Quality Indicator Initiative and other key projects to enable health system evidence-based decision making and planning integral to POGO strategic objectives. Reporting to the Senior Healthcare Analyst & Project Manager, the Healthcare Analyst will work closely with POGO Clinical/Executive Leads, program managers and staff members.
Abbreviated Candidate Education/Experience:
- Master’s degree in Epidemiology (preferred), Public Health, Health Sciences, Health Research Methodology or recognized equivalent
- 3-5 years of practical and related work experience in applying relevant methods and population-based data analyses to answer complex health questions and/or support health policy development
- Experience in health system planning and/or decision support is an asset
JOB POSTING: Manager, Clinical Trials and Clinical Informatics in the department of hematology/oncology at Sick Kids
INTERNAL candidates apply here. Full job posting for EXTERNAL candidates below can be found at https://career.sickkids.ca:8001/psc/CRPRD/CAREER/HRMS/c/HRS_HRAM.HRS_APP_SCHJOB.GBL?Page=HRS_APP_JBPST&Action=U&FOCUS=Applicant&SiteId=1&JobOpeningId=11049&PostingSeq=1
Are you a strategic and visionary leader who is passionate about improving efficiencies, enhancing workflow, and advancing patient care? Are you looking for an opportunity to utilize your clinical, informatics and/or clinical trials expertise to develop ways to enhance clinical trials, research and informatics?
Sick Kids is looking for a Manager to lead all aspects of the Clinical Trials and Clinical Informatics program and to develop and maintain relationships across the program. In this role, you will work closely with the unit medical director and divisional director to ensure achievement of strategic goals as they relate to decision-making, implementation, ongoing evaluation and maintenance of technologies and clinical information systems used throughout the Hematology, Oncology and Bone Marrow Transplant/Cellular Therapy program. You will have the opportunity to recognize and implement workflow process improvements involving informatics and you will develop, communicate and implement a strategic plan for the ongoing development and growth of the clinical trials program.
Abbreviated candidate education/experience (see posting for complete list):
- Post secondary degree in a health/research related field.
- Certified Clinical Research Professional (CCRP); strongly preferred
- 3-5+ years of formal people management experience.
- 3-5+ years experience with Clinical Informatics and/or Clinical Trials is a strong asset.
- 3-5+ years of Clinical experience within Hematology, Oncology and BMT/CT is a strong asset
- Strong relationship building skills and the ability to manage multiple stakeholders.
- Excellent working knowledge of clinical informatics systems and workflow processes/improvements and/or of Clinical Trials Research.
- Experience in leading, managing clinical trials in an hospital academic institution is preferred
For a full job description and to apply, go to: www.staffcareers.ubc.ca/33837
To coordinate data collection and management for the local component of the national pediatric oncology surveillance program (CYP-C: Cancer in Young People in Canada). The project is supported by a grant from the Federal Public Health Agency of Canada. Data for children diagnosed in British Columbia prior to the start of the project will be obtained from medical records and entered into a national database. The RT3 works with physicians and staff in the Data Management office and Oncology clinic. The RT3’s office is located in the Shaughnessy Building.
Qualifications–selected (see posting for full list)
- Undergraduate degree in a relevant discipline or Graduation from a technical college or institute.
- Health Information Technologist/Health Information Management Diploma or unit clerk certificate (preferred).
- Certified member of SoCRA (Society of Clinical Research Associates) preferred.
- Minimum of 3 years related experience or the equivalent combination of education and experience.
- Knowledge of medical terminology and patient record systems required.
- Experience in an oncology setting preferred. Demonstrated knowledge and experience with Pediatric oncology an asset.